对心房动的预防措施和治疗选择
Deutsches Arzteblatt international
|June 17, 2025
概括
在德国,心房动 (AF) 影响了160万人. 本指南强调口服抗凝药 (OAC),早期节律控制和导管切除,以改善患者的治疗结果和降低死亡率.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 心房动 (AF) 是德国最常见的心律失常症,影响大约160万个人.
- 有效的AF管理,包括预防,治疗和抗凝药,对于提高患者的生活质量和降低死亡率至关重要.
研究的目的:
- 建立德国第一个关于心房动的临床实践指南.
- 为AF的预防和管理提供基于证据的建议.
主要方法:
- 根据AWMF的规则工作指南进行开发.
- 系统的文献搜索和证据的评估,多个医学专业协会的参与.
主要成果:
- AF分类包括偏激性,持久性,长期持久性和永久性类型.
- 脑膜炎使死亡率增加1.5至2倍,中风风险增加4至5倍;由于数据相互矛盾,不建议进行一般查.
- 建议使用CHA2DS2-VA评分进行血栓栓塞风险评估,这表明口服抗凝剂 (OAC) 评分≥2.2.
- 早期节律控制和导管切除显示出显著的益处,特别是在心肌梗塞和心力衰竭患者.
结论:
- 指南建议旨在加强AF预防,潜在地降低患病率和不良结果.
- 有证据支持评估OAC的指示,早期节律控制和导管切除,特别是在阳性AF和心力衰竭方面.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
114
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
114
Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
174
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
174
Aortic Regurgitation III: Medical Management
53
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
53


